Article: Invitrogen Forms Biodefense Unit For Detection, Vaccines.

Staff Writer

With an expanding market for products to fight bioterrorism, Invitrogen Corp. formed a new wholly owned subsidiary called Biological Defense Systems Inc. (BDS) to focus on research and development of vaccines, therapeutics and detection technologies.

The venture, to be located in Frederick, Md., will consolidate the company's biosecurity applications.

"The actual nuts and bolts of why we did this is we find that with a subsidiary, it is easier to work with the government, and it's easier to manage the business with respect to some of the security concerns," said James Gilmore, director at BDS.

BDS will keep a close eye on ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!